{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:23:23Z","timestamp":1790007803859,"version":"4.0.1"},"reference-count":46,"publisher":"The Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9,1]]},"abstract":"<jats:p>High systemic exposures to calcitriol are necessary for optimal antitumor effects. Human prostate cancer PC3 cells are insensitive to calcitriol treatment. Therefore, we investigated whether the inhibition of 24-hydroxylase (CYP24A1), the major calcitriol inactivating enzyme, by ketoconazole (KTZ) or RC2204 modulates calcitriol serum pharmacokinetics and biologic effects. Dexamethasone (Dex) was added to minimize calcitriol-induced hypercalcemia and as a steroid replacement for the KTZ inhibition of steroid biosynthesis cytochrome P450 enzymes. KTZ effectively inhibited time-dependent calcitriol-inducible CYP24A1 protein expression and enzyme activity in PC3 cells and C3H\/HeJ mouse kidney tissues. Systemic calcitriol exposure area under the curve was higher in mice treated with a combination of calcitriol and KTZ than with calcitriol alone. KTZ and Dex synergistically potentiated calcitriol-mediated antiproliferative effects in PC3 cells in vitro; this effect was associated with enhanced apoptosis. After treatment with calcitriol and KTZ\/Dex, although caspase-9 and caspase-3 were not activated and cytochrome c was not released by mitochondria, caspase-8 was activated and the truncated Bid protein level was increased. Translocation of apoptosis-inducing factor to the nucleus was observed, indicating a role of the apoptosis-inducing factor-mediated and caspase-independent apoptotic pathways. Calcitriol and KTZ\/Dex combination suppressed the clonogenic survival and enhanced the growth inhibition observed with calcitriol alone in PC3 human prostate cancer xenograft mouse model. Our results show that the administration of calcitriol in combination with CYP24A1 inhibitor enhances antiproliferative effects, increases systemic calcitriol exposure, and promotes the activation of caspase-independent apoptosis pathway.<\/jats:p>","DOI":"10.1210\/en.2009-1156","type":"journal-article","created":{"date-parts":[[2010,6,30]],"date-time":"2010-06-30T21:10:24Z","timestamp":1277932224000},"page":"4301-4312","source":"Crossref","is-referenced-by-count":87,"title":["CYP24A1 Inhibition Enhances the Antitumor Activity of Calcitriol"],"prefix":"10.1210","volume":"151","author":[{"given":"Josephia R.","family":"Muindi","sequence":"first","affiliation":[{"name":"Departments of Medicine (J.R.M., K.L.E., D.L.T.), Roswell Park Cancer Institute, Buffalo, New York 14263"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Dong","family":"Yu","sequence":"first","affiliation":[{"name":"Departments of Pharmacology and Therapeutics (W.-D.Y., Y.M., R.-X.K., C.S.J.), Roswell Park Cancer Institute, Buffalo, New York 14263"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyu","family":"Ma","sequence":"first","affiliation":[{"name":"Departments of Pharmacology and Therapeutics (W.-D.Y., Y.M., R.-X.K., C.S.J.), Roswell Park Cancer Institute, Buffalo, New York 14263"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristie L.","family":"Engler","sequence":"first","affiliation":[{"name":"Departments of Medicine (J.R.M., K.L.E., D.L.T.), Roswell Park Cancer Institute, Buffalo, New York 14263"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Xian","family":"Kong","sequence":"first","affiliation":[{"name":"Departments of Pharmacology and Therapeutics (W.-D.Y., Y.M., R.-X.K., C.S.J.), Roswell Park Cancer Institute, Buffalo, New York 14263"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald L.","family":"Trump","sequence":"first","affiliation":[{"name":"Departments of Medicine (J.R.M., K.L.E., D.L.T.), Roswell Park Cancer Institute, Buffalo, New York 14263"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candace S.","family":"Johnson","sequence":"first","affiliation":[{"name":"Departments of Pharmacology and Therapeutics (W.-D.Y., Y.M., R.-X.K., C.S.J.), Roswell Park Cancer Institute, Buffalo, New York 14263"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2010,6,30]]},"reference":[{"key":"2020071612413132800_R1","first-page":"2551","article-title":"Vitamin D compounds: clinical development as cancer therapy and prevention agents.","volume":"26","author":"Trump","year":"2006","journal-title":"Anticancer Res"},{"key":"2020071612413132800_R2","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/(SICI)1097-0215(19990531)81:5<730::AID-IJC11>3.0.CO;2-Q","article-title":"Inhibition of angiogenesis as a mechanism for inhibition by 1\u03b1-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 of colon carcinogenesis induced by azoxymethane in Wistar rats.","volume":"81","author":"Iseki","year":"1999","journal-title":"Int J Cancer"},{"key":"2020071612413132800_R3","doi-asserted-by":"crossref","first-page":"8565","DOI":"10.1158\/0008-5472.CAN-06-0905","article-title":"Differential antiproliferative effects of calcitriol on tumor-derived and matrigel-derived endothelial cells.","volume":"66","author":"Chung","year":"2006","journal-title":"Cancer Res"},{"key":"2020071612413132800_R4","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1158\/0008-5472.CAN-08-2307","article-title":"Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo.","volume":"69","author":"Chung","year":"2009","journal-title":"Cancer Res"},{"key":"2020071612413132800_R5","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0090-4295(97)00408-1","article-title":"Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.","volume":"50","author":"Getzenberg","year":"1997","journal-title":"Urology"},{"key":"2020071612413132800_R6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jnci\/90.2.134","article-title":"Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone.","volume":"90","author":"Yu","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"2020071612413132800_R7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000076336","article-title":"Pharmacokinetics of 1\u03b1,25-dihydroxyvitamin D3 in normal mice after systemic exposure to effective and safe antitumor doses.","volume":"66","author":"Muindi","year":"2004","journal-title":"Oncology"},{"key":"2020071612413132800_R8","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00280-008-0678-x","article-title":"In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors.","volume":"62","author":"Rassnick","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"2020071612413132800_R9","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/S0022-5347(01)63236-1","article-title":"Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol).","volume":"159","author":"Gross","year":"1998","journal-title":"J Urol"},{"key":"2020071612413132800_R10","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/cncr.11179","article-title":"High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma.","volume":"97","author":"Beer","year":"2003","journal-title":"Cancer"},{"key":"2020071612413132800_R11","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/cncr.21890","article-title":"Phase II trial of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancer.","volume":"106","author":"Trump","year":"2006","journal-title":"Cancer"},{"key":"2020071612413132800_R12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1200\/JCO.2006.06.8197","article-title":"Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT investigators.","volume":"25","author":"Beer","year":"2007","journal-title":"J Clin Oncol"},{"key":"2020071612413132800_R13","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1067\/mcp.2002.129305","article-title":"Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel","volume":"72","author":"Muindi","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"2020071612413132800_R14","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1158\/1078-0432.CCR-06-1165","article-title":"A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors.","volume":"13","author":"Fakih","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2020071612413132800_R15","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/1097-0142(20010615)91:12<2431::AID-CNCR1278>3.0.CO;2-3","article-title":"A Phase I trial of pulse calcitriol in patients with refractory malignancies: pulse dosing permits substantial dose escalation.","volume":"91","author":"Beer","year":"2001","journal-title":"Cancer"},{"key":"2020071612413132800_R16","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.tibs.2004.10.005","article-title":"Enzymes involved in the activation and inactivation of vitamin D.","volume":"29","author":"Prosser","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"2020071612413132800_R17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev.nutr.22.120501.150216","article-title":"Hydroxylase enzymes of the vitamin D pathway: expression, function, and regulation.","volume":"22","author":"Omdahl","year":"2002","journal-title":"Annu Rev Nutr"},{"key":"2020071612413132800_R18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00280-005-0059-7","article-title":"Expression of VDR and CYP24A1 mRNA in human tumors.","volume":"57","author":"Anderson","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"2020071612413132800_R19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/annonc\/mdh056","article-title":"Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer.","volume":"15","author":"Mimori","year":"2004","journal-title":"Ann Oncol"},{"key":"2020071612413132800_R20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/75985","article-title":"Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene.","volume":"25","author":"Albertson","year":"2000","journal-title":"Nat Genet"},{"key":"2020071612413132800_R21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0960-0760(95)00256-1","article-title":"Enhancement of antiproliferative activity of 1\u03b1,25-dihydroxyvitamin D3 (analogs) by cytochrome P450 enzyme inhibitors is compound- and cell-type specific.","volume":"57","author":"Zhao","year":"1996","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071612413132800_R22","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0022-5347(05)64525-9","article-title":"Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analogue EB 1089 in prostate cancer cells.","volume":"168","author":"Peehl","year":"2002","journal-title":"J Urol"},{"key":"2020071612413132800_R23","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1210\/endo.140.5.6698","article-title":"Liarozole acts synergistically with 1\u03b1,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity.","volume":"140","author":"Ly","year":"1999","journal-title":"Endocrinology"},{"key":"2020071612413132800_R24","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1200\/JCO.1989.7.8.1093","article-title":"High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects.","volume":"7","author":"Trump","year":"1989","journal-title":"J Clin Oncol"},{"key":"2020071612413132800_R25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0090-4295(02)01581-9","article-title":"Secondary hormonal therapies in the treatment of prostate cancer.","volume":"60","author":"Oh","year":"2002","journal-title":"Urology"},{"key":"2020071612413132800_R26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.marenvres.2008.02.072","article-title":"Perturbation of gene expression and steroidogenesis with in vitro exposure of fathead minnow ovaries to ketoconazole.","volume":"66","author":"Perkins","year":"2008","journal-title":"Mar Environ Res"},{"issue":"Suppl 3","key":"2020071612413132800_R27","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1093\/ajhp\/58.suppl_3.S8","article-title":"Conventional treatment of hypercalcemia of malignancy","volume":"58","author":"Davidson","year":"2001","journal-title":"Am J Health Syst Pharm"},{"key":"2020071612413132800_R28","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/bmj.290.6470.748","article-title":"Prolonged hypercalcaemia after industrial exposure to vitamin D3.","volume":"290","author":"Jibani","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2020071612413132800_R29","first-page":"1043","article-title":"Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis.","volume":"7","author":"Hershberger","year":"2001","journal-title":"Clin Cancer Res"},{"key":"2020071612413132800_R30","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jsbmb.2006.12.060","article-title":"CYP24 splicing variants are associated with different patterns of constitutive and calcitriol-inducible CYP24 activity in human prostate cancer cell lines.","volume":"103","author":"Muindi","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071612413132800_R31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00280-006-0247-0","article-title":"Monocyte fructose 1,6-bisphosphatase and cytidine deaminase enzyme activities: potential pharmacodynamic measures of calcitriol effects in cancer patients.","volume":"59","author":"Muindi","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"2020071612413132800_R32","doi-asserted-by":"crossref","first-page":"8704","DOI":"10.1074\/jbc.M608894200","article-title":"Epigenetic silencing of CYP24 in tumor-derived endothelial cells contributes to selective growth inhibition by calcitriol.","volume":"282","author":"Chung","year":"2007","journal-title":"J Biol Chem"},{"key":"2020071612413132800_R33","doi-asserted-by":"crossref","first-page":"8131","DOI":"10.1158\/0008-5472.CAN-06-1333","article-title":"Role of nongenomic activation of phosphatidylinositol 3-kinase\/Akt and mitogen-activated protein kinase\/extracellular signal-regulated kinase kinase\/extracellular signal-regulated kinase 1\/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells.","volume":"66","author":"Ma","year":"2006","journal-title":"Cancer Res"},{"key":"2020071612413132800_R34","first-page":"2644","article-title":"1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21 (Waf1\/Cip1) in vitro and in vivo.","volume":"59","author":"Hershberger","year":"1999","journal-title":"Cancer Res"},{"key":"2020071612413132800_R35","first-page":"1339","article-title":"A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy.","volume":"5","author":"Smith","year":"1999","journal-title":"Clin Cancer Res"},{"key":"2020071612413132800_R36","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0092-8674(00)81590-1","article-title":"Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis.","volume":"94","author":"Li","year":"1998","journal-title":"Cell"},{"key":"2020071612413132800_R37","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1038\/sj.onc.1207517","article-title":"Role of AIF in caspase-dependent and caspase-independent cell death.","volume":"23","author":"Cregan","year":"2004","journal-title":"Oncogene"},{"key":"2020071612413132800_R38","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1210\/en.2004-1116","article-title":"Altered pharmacokinetics of 1\u03b1,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.","volume":"146","author":"Masuda","year":"2005","journal-title":"Endocrinology"},{"key":"2020071612413132800_R39","first-page":"667","article-title":"Apoptosis induction by 1\u03b1,25-dihydroxyvitamin D3 in prostate cancer.","volume":"1","author":"Guzey","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"2020071612413132800_R40","first-page":"2304","article-title":"Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.","volume":"60","author":"Di\u0301az","year":"2000","journal-title":"Cancer Res"},{"key":"2020071612413132800_R41","doi-asserted-by":"crossref","first-page":"26365","DOI":"10.1074\/jbc.M010101200","article-title":"Vitamin D3 -induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1.","volume":"276","author":"McGuire","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071612413132800_R42","doi-asserted-by":"crossref","first-page":"53213","DOI":"10.1074\/jbc.M410395200","article-title":"Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase.","volume":"279","author":"Jiang","year":"2004","journal-title":"J Biol Chem"},{"key":"2020071612413132800_R43","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2002-07-1984","article-title":"The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro.","volume":"101","author":"Pepper","year":"2003","journal-title":"Blood"},{"key":"2020071612413132800_R44","doi-asserted-by":"crossref","first-page":"30738","DOI":"10.1074\/jbc.M201558200","article-title":"Calcium and calpain as key mediators of apoptosis-like death induced by vitamin D compounds in breast cancer cells.","volume":"277","author":"Mathiasen","year":"2002","journal-title":"J Biol Chem"},{"key":"2020071612413132800_R45","doi-asserted-by":"crossref","first-page":"9101","DOI":"10.1074\/jbc.M006876200","article-title":"Role of mitochondria and caspases in vitamin D-mediated apoptosis of MCF-7 breast cancer cells.","volume":"276","author":"Narvaez","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071612413132800_R46","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1365-2613.2009.00660.x","article-title":"Chronic treatment with sildenafil stimulates Leydig cell and testosterone secretion.","volume":"90","author":"Saraiva","year":"2009","journal-title":"Int J Exp Pathol"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/151\/9\/4301\/9011893\/endo4301.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/151\/9\/4301\/9011893\/endo4301.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T17:34:24Z","timestamp":1594920864000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/151\/9\/4301\/2456899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,30]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2009-1156","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,30]]}}}